Accelerate Diagnostics, Inc Contracts & Agreements
80 Contracts & Agreements
- Business Finance (51 contracts)
- Business Operations (3)
- Human Resources (12)
- Uncategorized (14)
- Warrant Agency Agreement, dated January 23, 2024, between Accelerate Diagnostics, Inc. and Broadridge Corporate Issuer Solutions (Filed With SEC on January 25, 2024)
- Form of Subscription Agreement (Filed With SEC on January 25, 2024)
- Form of Warrant (Filed With SEC on January 18, 2024)
- Form of Pre-Funded Warrant (Filed With SEC on January 18, 2024)
- Form of Warrant Agency Agreement (Filed With SEC on January 18, 2024)
- Form of Underwriting Agreement (Filed With SEC on January 16, 2024)
- Form of Warrant (Filed With SEC on January 16, 2024)
- Form of Pre-Funded Warrant (Filed With SEC on January 16, 2024)
- Form of Warrant Agency Agreement (Filed With SEC on January 16, 2024)
- First Amendment to Securities Purchase Agreement, dated December 12, 2023, between the Company and the Jack W. Schuler Living Trust (Filed With SEC on December 13, 2023)
- First Amendment to Note Purchase Agreement, dated December 11, 2023, between the Company and certain investors named therein (Filed With SEC on December 13, 2023)
- First Amendment to Note Exchange Agreement, dated December 11, 2023, between the Company and certain investors named therein (Filed With SEC on December 13, 2023)
- Indenture, dated June 9, 2023, between the Company and U.S. Bank Trust Company, National Association (Filed With SEC on June 13, 2023)
- Note Exchange Agreement, date June 9, 2023, between the Company and certain investors named therein (Filed With SEC on June 13, 2023)
- Note Purchase Agreement, dated June 9, 2023, between the Company and certain investors named therein (Filed With SEC on June 13, 2023)
- Form of Security Agreement, dated June 9, 2023, between the Company, as issuer, subsidiaries of the Company, as guarantors, and U.S. Bank Trust Company, National Association, as... (Filed With SEC on June 13, 2023)
- Consent and Amendment No. 1 to Secured Promissory Note, dated June 9, 2023, between the Company and the Jack W. Schuler Living Trust (Filed With SEC on June 13, 2023)
- Amendment No. 1 to Securities Purchase Agreement, dated June 9, 2023, between the Company and the Jack W. Schuler Living Trust (Filed With SEC on June 13, 2023)
- New Securities Purchase Agreement, dated June 9, 2023, between the Company and the Jack W. Schuler Living Trust (Filed With SEC on June 13, 2023)
- First Amendment to the Accelerate Diagnostics, Inc. 2022 Omnibus Equity Incentive Plan (Filed With SEC on May 24, 2023)
- David Patience Change in Employment Status (Filed With SEC on May 15, 2023)
- Restructuring Support Agreement, dated as of April 21, 2023 between the Company and Consenting Stakeholders (Filed With SEC on April 24, 2023)
- Description of our Capital Stock Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 31, 2023)
- Forbearance Agreement, dated as of March 9, 2023, by and among the Company, the Ad Hoc Noteholder Group and the Trustee (Filed With SEC on March 14, 2023)
- Separation Agreement and Release, dated December 8, 2022, by and between the Company and Ron Price (Filed With SEC on December 13, 2022)
- Sales and Marketing Agreement, dated as of August 15, 2022, by and between the Registrant and Becton, Dickinson and Company (Filed With SEC on November 14, 2022)
- Underwriting Agreement, dated August 18, 2022, by and between Accelerate Diagnostics, Inc. and William Blair & Company, L.L.C., as representative of the several underwriters named... (Filed With SEC on August 23, 2022)
- Exchange Agreement, dated as of August 15, 2022, by and between the Company and the Jack W. Schuler Living Trust (Filed With SEC on August 15, 2022)
- Secured Promissory Note, dated as of August 15, 2022, by the Company in favor of the Jack W. Schuler Living Trust (Filed With SEC on August 15, 2022)
- Warrant, dated as of August 15, 2022, issued to the Jack W. Schuler Living Trust (Filed With SEC on August 15, 2022)
- Security Agreement, dated as of August 15, 2022, by and between the Company and the Jack W. Schuler Living Trust (Filed With SEC on August 15, 2022)
- Accelerate Diagnostics, Inc. 2022 Omnibus Equity Incentive Plan (Filed With SEC on May 17, 2022)
- Securities Purchase Agreement, dated March 24, 2022, by and between Accelerate Diagnostics, Inc. and the Jack W. Schuler Living Trust (Filed With SEC on March 25, 2022)
- Description of our Capital Stock Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 14, 2022)
- Rescission Agreement, dated September 17, 2021, by and among Accelerate Diagnostics, Inc., the Tanya Eva Schuler Trust, the Therese Heidi Schuler Trust, Schuler Grandchildren LLC... (Filed With SEC on September 23, 2021)
- Securities Purchase Agreement, dated September 22, 2021, by and among Accelerate Diagnostics, Inc., the Tanya Eva Schuler Trust, the Therese Heidi Schuler Trust and Schuler... (Filed With SEC on September 23, 2021)
- Form of Exchange Agreement (Filed With SEC on September 23, 2021)
- Sales Agreement, dated as of May 28, 2021, by and among Accelerate Diagnostics, Inc. and William Blair & Company, L.L.C (Filed With SEC on May 28, 2021)
- Securities Purchase Agreement, dated December 24, 2020, by and among Accelerate Diagnostics, Inc. and the purchasers party thereto (Filed With SEC on December 28, 2020)
- Registration Rights Agreement, dated December 24, 2020, by and among Accelerate Diagnostics, Inc. and the purchasers party thereto (Filed With SEC on December 28, 2020)
- Addendum A to Promissory Note, dated April 14, 2020, by and between Registrant and Zions (Filed With SEC on November 6, 2020)
- Consulting Services Agreement by and between Registrant and Romney Humphries, dated May 5, 2020 (Filed With SEC on August 10, 2020)
- Sixth Amendment to the Accelerate Diagnostics, Inc. 2012 Omnibus Equity Incentive Plan (Filed With SEC on May 14, 2020)
- Promissory Note, dated April 14, 2020, by and between Accelerate Diagnostics, Inc. and Zions Bancorporation, N.A. dba National Bank of Arizona (Filed With SEC on April 20, 2020)
- 2020 Salary Waiver and Nonqualified Stock Option Grant Plan (Filed With SEC on April 8, 2020)
- Form of 2020 Salary Waiver Agreement (Filed With SEC on April 8, 2020)
- Description of our Capital Stock Registered Pursuant to Section 12 of the Securties Exchange Act of 1934 (Filed With SEC on February 28, 2020)
- Transition Agreement, Part-Time Employment Agreement, and General Release of Claims between Lawrence Mehren and the Registrant, dated December 1, 2019 (Filed With SEC on February 28, 2020)
- Agreement between Registrant and Jack Phillips, dated as of January 31, 2020 (Filed With SEC on February 28, 2020)
- Securities Purchase Agreement, dated August 20, 2019, between Accelerate Diagnostics, Inc. and John J. Phillips Investment Irrevocable Trust, dated July 31, 2019 (Filed With SEC on August 21, 2019)
- Offer Letter between Accelerate Diagnostics, Inc. and John J. Phillips, dated August 6, 2019 (Filed With SEC on August 8, 2019)
- Nonqualified Stock Option Agreement between Accelerate Diagnostics, Inc. and John J. Phillips, dated August 6, 2019 (Filed With SEC on August 8, 2019)
- Fifth Amendment to the Accelerate Diagnostics, Inc. 2012 Omnibus Equity Incentive Plan (Filed With SEC on May 15, 2019)
- Specimen Common Stock Certificate (Filed With SEC on March 1, 2019)
- Separation Agreement and General Release, dated November 25, 2018, between Juan Manuel Martn Duaiges and the Registrant (Filed With SEC on March 1, 2019)
- 2019 Salary Waiver and Nonqualified Stock Option Grant Plan (Filed With SEC on December 28, 2018)
- Form of Salary Waiver Agreement (Filed With SEC on December 28, 2018)
- Fourth Amendment to the Accelerate Diagnostics, Inc. 2012 Omnibus Equity Incentive Plan (Filed With SEC on November 6, 2018)
- UK Sub-Plan under the Accelerate Diagnostics, Inc. 2012 Omnibus Equity Incentive Plan (Filed With SEC on November 6, 2018)
- Indenture, dated March 27, 2018 between Accelerate Diagnostics, Inc. and U.S. Bank National Association, as trustee (Filed With SEC on March 28, 2018)
- Purchase Agreement, dated March 22, 2018, between Accelerate Diagnostics, Inc. and J.P. Morgan Securities LLC, as representative of the several Initial Purchasers named in... (Filed With SEC on March 28, 2018)
- Forward Stock Purchase Transaction, dated March 22, 2018, between Accelerate Diagnostics, Inc. and JPMorgan Chase Bank, National Association, London Branch (Filed With SEC on March 28, 2018)
- UNDERWRITING AGREEMENT ACCELERATE DIAGNOSTICS, INC. 2,750,000 Shares of Common Stock Underwriting Agreement (Filed With SEC on May 15, 2017)
- UNDERWRITING AGREEMENT ACCELERATE DIAGNOSTICS, INC. 5,588,236 Shares of Common Stock Underwriting Agreement (Filed With SEC on December 15, 2015)
- ASSIGNMENT AND ASSUMPTION AGREEMENT (Filed With SEC on May 2, 2014)
- ACCELR8 TECHNOLOGY CORPORATION WARRANT (Filed With SEC on October 26, 2012)
- ACCELR8 TECHNOLOGY CORPORATION WARRANT (Filed With SEC on October 26, 2012)
- REGISTRATION RIGHTSAGREEMENT (Filed With SEC on October 26, 2012)
- ACCELR8TECHNOLOGY CORPORATION EMPLOYMENTAGREEMENT WITHTHOMAS V. GEIMER (Filed With SEC on October 26, 2012)
- AMENDMENT TO EMPLOYMENTAGREEMENT WITH THOMAS V. GEIMER (Filed With SEC on October 26, 2012)
- CONSULTING AGREEMENT (Filed With SEC on October 26, 2012)
- [ACCELR8 LETTERHEAD] (Filed With SEC on October 26, 2012)
- (GraphicOmitted - Pima County Logo) FacilitiesManagement 150 WEST CONGRESS, 3rd FLOOR TUCSON, ARIZONA 85701 (Filed With SEC on October 26, 2012)
- GRANT AGREEMENT between ARIZONA COMMERCE AUTHORITY, an agency of the State of Arizona, and ACCELR8TECHNOLOGIES CORPORATION, a Colorado corporation (Filed With SEC on October 26, 2012)
- Amendment #3 to the Letter of Intent (Filed With SEC on August 1, 2011)
- EXHIBIT 10.1 (Filed With SEC on February 14, 2011)
- Amendment #1 to the Evaluation Corporation Agreement (Filed With SEC on December 14, 2010)
- Amendment #1 to the Letter of Intent (Filed With SEC on December 14, 2010)
- EVALUATION AGREEMENT (Filed With SEC on September 16, 2010)
- LETTER OF INTENT (Filed With SEC on September 16, 2010)